COMMUNIQUÉS West-GlobeNewswire
-
Ipsen mourns the passing of Henri Beaufour, a founding family Board member
01/12/2025 -
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
01/12/2025 -
Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer
01/12/2025 -
Clue Unveils Our Year In Cycles: A Candid Look at How We Bled, Felt, Loved and Lived in 2025
01/12/2025 -
Clue Unveils Our Year In Cycles: A Candid Look at How We Bled, Felt, Loved and Lived in 2025
01/12/2025 -
Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform
30/11/2025 -
Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
30/11/2025 -
DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
30/11/2025 -
Konica Minolta Healthcare Launches New Floor-Mounted Digital Radiography Systems at RSNA 2025
30/11/2025 -
At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care
30/11/2025 -
Anabolic Steroids Alternatives: Muscle Building Supplements from CrazyBulk | Most Selling Muscular Endurance Supplements Bodybuilders Use For Peak Performance & Strength Building in 2025
29/11/2025 -
Algernon Closes Second Tranche of Private Placement Financing
29/11/2025 -
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
29/11/2025 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
28/11/2025 -
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
28/11/2025 -
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
28/11/2025 -
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
28/11/2025 -
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
28/11/2025 -
Les Hôpitaux Shriners pour enfants Canada et l’Hôpital pour enfants du Centre des sciences de la santé de London lancent un programme de recherche historique pour faire progresser les soins liés aux maladies osseuses rares chez l’enfant
28/11/2025
Pages